A hot potato: Not everything that Sam Altman touches is as successful as ChatGPT. The OpenAI boss' crypto-based World project – formerly called Worldcoin – has an ambitious plan to scan a billion ...
Our round-up of recent biotech financings is headed by a massive $1.25 billion round for genetic medicines specialist BridgeBio Pharma, with smaller rounds for Tr1X, Comanche Biopharma, Ratio ...
Sanofi has bolstered its immuno-oncology pipeline with a $1 billion agreement to acquire Amunix Pharma of the US – its fourth bolt-on deal of 2021. South San Francisco-based Amunix specialises in ...
AbbVie is ending an 11-year agreement with Alphabet’s Calico Labs, according to an internal email obtained by Stat. Now, the intensive project—which is focused on age-related diseases, including ...
Falsehood flies, and truth comes limping after it, so that when men come to be undeceived, it is too late; the jest is over, and the tale hath had its effect: like a man, who hath thought of a good ...
Hosted on MSN
High-Flying Biotech Stock Sets Up After 96% Pop; Profitability In Sight As Key Drug Sales Double
Among big winners in the stock market this year, Alnylam PharmaceuticalsALNY has climbed amid increasing uptake of its chief drug, Amvuttra. The stock did retreat from its all-time high of 495.55 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback